Measles Virus Antibodies IgM, Qualitative (Serum)
The study is designed for qualitative detection of IgM class antibodies to the measles virus.
Used for diagnosing acute primary measles infection.
Prescribed upon appearance of characteristic clinical symptoms: high fever, catarrhal symptoms (cough, runny nose, conjunctivitis), Koplik spots, maculopapular rash.
Applied after contact with a measles patient for early laboratory confirmation of infection.
Important for timely diagnosis, patient isolation, and anti-epidemic measures.
What the test assesses:
– Presence or absence of IgM class antibodies to the measles virus.
– Active phase of the infectious process.
– Recent primary infection with the measles virus.
Biomaterial: Venous blood (serum)
– Submit fasting.
– Drinking still water is allowed.
– It is advisable to avoid physical exertion and stress before blood collection.
Medications:
– It is recommended to submit the test before starting antiviral and immunomodulatory therapy.
– Immunoglobulin administration may affect the test result.
– When taking any medications, be sure to inform the doctor or indicate them when submitting the test.
Recommended for testing:
– When measles is clinically suspected.
– With fever, rash, and pronounced catarrhal symptoms.
– When examining children with suspected measles.
– During measles outbreaks and examination of contact persons.
– Positive result (IgM detected): confirms acute primary measles infection; the patient is considered contagious and subject to isolation.
– Negative result (IgM not detected): active infection is unlikely; for early disease stages, repeat testing in 5-7 days is recommended.
Important — results should be interpreted together with the clinical picture, epidemiological history, and Measles IgG results.
